Date:
Location:
"The Biotechnology Edge”
Insights from Lab Bench to Patient Bedside
LECTURE 7
May 1st, 2019
5:00 - 6:00pm
Cannon Room, HMS
Food will be provided!
RSVP!!
Choosing a Modality
We will introduce Amgen’s broad toolkit of drug modalities and describe how we choose the “right” modality for drug discovery, focusing on biologic medicines.
Speaker: Hao Chen, PhD
Hao is a Principal Scientist in Biologics at Amgen. He started his industrial career at Amgen in 2006 as a scientist in the structure biology group and currently is a group leader in Protein Technologies, Biologics. Hao’s work is focused on enabling and accelerating the Amgen discovery research including small molecule and biologics therapeutic programs by utilizing cutting-edge protein engineering and protein production technologies.